Morabito, A., Piccirillo, M.C., Falasconi, F., et al. (2009) Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions. Oncologist, 14, 378-390.